Suppr超能文献

膀胱癌腹腔镜膀胱切除术的系统评价与Meta分析

Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer.

作者信息

Zhu Jialiang, Lu Ziwen, Chen Wanbo, Ke Mang, Cai Xianguo

机构信息

Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

出版信息

Transl Androl Urol. 2022 Jan;11(1):67-78. doi: 10.21037/tau-21-1076.

Abstract

BACKGROUND

This study aimed to systematically evaluate the efficacy of laparoscopic radical cystectomy (LRC) surgical therapy in patients with bladder cancer (BC), and to provide evidence for the clinical treatment of BC.

METHODS

The Embase, Ovid, PubMed, Medline, Springer, and Web of Sciences database were searched to screen articles with clinical controlled trials on LRC treatment of BC. The Cochrane Handbook 5.0.2 software and Review Manager 5.3 software were adopted to evaluate the risk of bias and to perform a meta-analysis of the included articles in this study.

RESULTS

A total of 12 articles were obtained, including 1,283 research cases. The meta-analysis results showed that relative to the control group (Ctrl), the observation group (Observ group) had significantly lower intraoperative blood loss (IBL) after LRC [mean difference (MD) =-458.75; 95% confidential interval (CI): -505.75 to -411.76; Z=19.13; P<0.00001], blood transfusion rate (BTR) (odds ratio =0.36; 95% CI: 0.13-0.94; Z=2.08; and P=0.04), use of analgesics (MD =-24.53; 95% CI: -39.04 to -10.01; Z=3.31; and P=0.0009), and incidence of postoperative complications (Risk ratio =0.58; 95% CI: 0.39-0.85; Z=2.77; and P=0.006). However, and the length of hospital stay could not be shortened (MD =-2.43; 95% CI: -4.83 to -0.02; Z=1.98; and P=0.05).

DISCUSSION

LRC treatment of BC could effectively reduce the amount of IBS, and lower the intraoperative BTR, use of analgesics, and incidence of postoperative complications. Therefore, it could be used in the clinical surgical treatment of BC patients.

摘要

背景

本研究旨在系统评价腹腔镜根治性膀胱切除术(LRC)治疗膀胱癌(BC)患者的疗效,为BC的临床治疗提供依据。

方法

检索Embase、Ovid、PubMed、Medline、Springer和Web of Sciences数据库,筛选有关LRC治疗BC的临床对照试验文章。采用Cochrane手册5.0.2软件和Review Manager 5.3软件评估偏倚风险,并对本研究纳入的文章进行荟萃分析。

结果

共获得12篇文章,包括1283例研究病例。荟萃分析结果显示,与对照组(Ctrl)相比,观察组(Observ组)LRC术后术中失血量(IBL)显著更低[平均差(MD)=-458.75;95%置信区间(CI):-505.75至-411.76;Z=19.13;P<0.00001]、输血率(BTR)(比值比=0.36;95%CI:0.13-0.94;Z=2.08;P=0.04)、镇痛药使用量(MD=-24.53;95%CI:-39.04至-10.01;Z=3.31;P=0.0009)及术后并发症发生率(风险比=0.58;95%CI:0.39-0.85;Z=2.77;P=0.006)。然而,住院时间未能缩短(MD=-2.43;95%CI:-4.83至-0.02;Z=1.98;P=0.05)。

讨论

LRC治疗BC可有效减少IBS量,降低术中BTR、镇痛药使用量及术后并发症发生率。因此,可用于BC患者的临床手术治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e88/8824818/d87bd92e364f/tau-11-01-67-f1.jpg

相似文献

1
Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer.
Transl Androl Urol. 2022 Jan;11(1):67-78. doi: 10.21037/tau-21-1076.
3
Robotic-assisted versus standard laparoscopic radical cystectomy in bladder cancer: A systematic review and meta-analysis.
Front Oncol. 2022 Nov 9;12:1024739. doi: 10.3389/fonc.2022.1024739. eCollection 2022.
5
A systematic review and meta-analysis of catheter ablation for atrial fibrillation.
Ann Palliat Med. 2021 Oct;10(10):10542-10555. doi: 10.21037/apm-21-2313.
8
Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.
Eur Urol. 2015 Mar;67(3):376-401. doi: 10.1016/j.eururo.2014.12.007. Epub 2015 Jan 2.
9
Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer.
J Endourol. 2013 Sep;27(9):1083-95. doi: 10.1089/end.2013.0084. Epub 2013 Aug 2.
10
Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies.
PLoS One. 2014 May 16;9(5):e95667. doi: 10.1371/journal.pone.0095667. eCollection 2014.

引用本文的文献

本文引用的文献

1
Laparoscopic versus open radical cystectomy in 607 patients with bladder cancer: Comparative survival analysis.
Int J Urol. 2021 Jun;28(6):673-680. doi: 10.1111/iju.14537. Epub 2021 Mar 13.
2
Bladder Cancer: A Review.
JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598.
3
Treatment of muscle-invasive and advanced bladder cancer in 2020.
CA Cancer J Clin. 2020 Sep;70(5):404-423. doi: 10.3322/caac.21631. Epub 2020 Aug 7.
5
Overview of VI-RADS in Bladder Cancer.
AJR Am J Roentgenol. 2020 Jun;214(6):1259-1268. doi: 10.2214/AJR.20.22763. Epub 2020 Apr 14.
6
An EMT-related gene signature for the prognosis of human bladder cancer.
J Cell Mol Med. 2020 Jan;24(1):605-617. doi: 10.1111/jcmm.14767. Epub 2019 Oct 28.
7
Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes.
Clin Genitourin Cancer. 2019 Oct;17(5):e1048-e1053. doi: 10.1016/j.clgc.2019.06.007. Epub 2019 Jun 19.
8
Organ preservation in bladder cancer: an opportunity for truly personalized treatment.
Nat Rev Urol. 2019 Sep;16(9):511-522. doi: 10.1038/s41585-019-0199-x. Epub 2019 Jun 13.
9
Trimodality therapy for bladder cancer: modern management and future directions.
Curr Opin Urol. 2019 May;29(3):210-215. doi: 10.1097/MOU.0000000000000601.
10
Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort.
Int J Urol. 2019 Apr;26(4):493-498. doi: 10.1111/iju.13917. Epub 2019 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验